VTVT
vTv Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$124.80M
P/E Ratio
—
EPS
$-3.20
Beta
0.40
52W High
$44.00
52W Low
$14.00
50-Day MA
$36.52
200-Day MA
$28.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About vTv Therapeutics Inc
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet unmet medical needs.
Fundamentals
| Revenue (TTM) | 17,000 |
| Gross Profit (TTM) | $-17.86M |
| EBITDA | $-32.79M |
| Operating Margin | 0.00% |
| Return on Equity | -78.90% |
| Return on Assets | -32.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.19 |
| Price-to-Book | 1.93 |
| Price-to-Sales (TTM) | 14852.65 |
| EV/Revenue | 2633.33 |
| EV/EBITDA | -2.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.94M |
| Float | $2.90M |
| % Insiders | 38.98% |
| % Institutions | 38.42% |
Historical Volatility
HV 10-Day
116.82%
HV 20-Day
84.94%
HV 30-Day
78.64%
HV 60-Day
94.50%
HV Rank
64.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($53.33 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 5/2/2026